Indication Landscape (Non-generic products): Marketed & R&D (PI to Filed)

 
 
ProductProduct
Generic NameGeneric Name
CompanyCompany
Pharmacological ClassPharmacological Class
Proprietary Level 2 WW Indication LaunchWW Indication Launch US Indication LaunchUS Indication Launch USA Indication Status (Current) Europe Indication LaunchEurope Indication Launch Europe Indication Status (Current) Japan Indication LaunchJapan Indication Launch Japan Indication Status (Current) China Indication Status (Current) RoW Indication Status (Current)
General biliary disorders                            
  Marketed Cholbam cholic acid Asklepion Pharmaceuticals Metabolic disease agent NME (Patented Compound) 02/04/2015 04/08/2015 Marketed 02/04/2015 Withdrawn - - - Phase III
  Cholbam cholic acid Retrophin Metabolic disease agent NME (Patented Compound) 02/04/2015 04/08/2015 Marketed 02/04/2015 Marketed - - - Phase III
  Orphacol cholic acid Laboratoires C.T.R.S. Metabolic disease agent NDA (Patented Compound) 04/07/2013 - - 04/07/2013 Marketed - - - -
  Compound Dantong Capsules herbal extract Tianyin Pharmaceutical Gastro-intestinal agent OTC (ex. USA Only) 30/06/2010 - - - - - - Marketed -
  Pankreaplex Mono curcuma xanthorizza extract Schaper & Brümmer Gastro-intestinal agent OTC (ex. USA Only) - - - - - - - - Marketed